ImmunityBio immunitybio.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

ImmunityBio is an immunotherapy company with a broad portfolio of biological molecules spanning albumin-linked chemotherapeutic, peptide, fusion protein, cytokine, monoclonal antibody, adenovirus and yeast vaccine therapies. This platform of technologies has enabled ImmunityBio to achieve late-stage clinical pipelines addressing both the innate (activated macrophage and natural killer cell) and the adaptive immune system (dendritic, CD4 and CD8 killer T cells). The pipeline constitutes over 40 i...Show all

ImmunityBio is an immunotherapy company with a broad portfolio of biological molecules spanning albumin-linked chemotherapeutic, peptide, fusion protein, cytokine, monoclonal antibody, adenovirus and yeast vaccine therapies. This platform of technolo...Show all

Company (IPO / Went public)

Phone: 310-883-1300

Fax:

9920 Jefferson Blvd

Culver City, 90232
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
ImmunityBio $301.6M Dec 21, 2020

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related ImmunityBio Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.